Disruption of inhibitory G-proteins mediates a reduction in atrial beta-adrenergic signaling by enhancing eNOS expression

Cardiovasc Res. 2005 Sep 1;67(4):613-23. doi: 10.1016/j.cardiores.2005.04.034.

Abstract

Objective: Cardiac parasympathetic nerve activity is reduced in most cardiovascular disease states, and this may contribute to enhanced cardiac sympathetic responsiveness. Disruption of inhibitory G-proteins (Gi) ablates the cholinergic pathway and increases cardiac endothelial nitric oxide (NO) synthase (eNOS) expression, suggesting that NO may offset the impaired attenuation of beta-adrenergic regulation of supraventricular excitability. To test this, we investigated the role of endogenous NO production on beta-adrenergic regulation of rate (HR), contraction (CR) and calcium (Ca2+) handling in atria following blockade of Gi-coupled muscarinic receptors.

Methods: Mice were administered pertussis toxin (PTx, n=105) or saline (C, n=100) intraperitoneally. After 3 days, we measured CR, HR, and NOS protein levels in isolated atria. Intracellular calcium (Ca2+) transients and Ca2+ current density (I(Ca)) were also measured in atrial myocytes.

Results: PTx treatment increased atrial myocyte eNOS protein levels compared to C (P<0.05). This did not affect basal atrial function but was associated with a significant reduction in the CR and HR response to isoprenaline (ISO) compared with C. NOS inhibition normalized responses in PTx atria with respect to responses in C atria (P<0.05), which were unaffected. Furthermore, PTx did not affect ISO-stimulated HR and CR in eNOS gene knockout mice (n=40). In agreement with these findings, the ISO-mediated increase in Ca2+ transient was suppressed in PTx-treated myocytes (P<0.05), whereas I(Ca) did not differ between groups.

Conclusion: eNOS-derived NO inhibits beta-adrenergic responses following disruption of Gi signaling. This suggests that increased eNOS expression may be a compensatory mechanism which reduces beta-adrenergic regulation of heart rate when cardiac parasympathetic control is impaired.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Agonists / pharmacology*
  • Animals
  • Blotting, Western / methods
  • Calcium / metabolism
  • Calcium Channels / metabolism
  • Caveolin 3 / metabolism
  • GTP-Binding Protein alpha Subunits, Gi-Go / antagonists & inhibitors*
  • Gene Expression / drug effects
  • Heart Atria
  • Immunohistochemistry / methods
  • Isoproterenol / pharmacology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microscopy, Confocal
  • Myocardial Contraction / drug effects
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type III / metabolism*
  • Patch-Clamp Techniques
  • Pertussis Toxin / pharmacology*
  • Signal Transduction / drug effects

Substances

  • Adrenergic beta-Agonists
  • Calcium Channels
  • Caveolin 3
  • Nitric Oxide
  • Nitric Oxide Synthase Type III
  • Pertussis Toxin
  • GTP-Binding Protein alpha Subunits, Gi-Go
  • Isoproterenol
  • Calcium